AL-'AQAR HEALTHCARE REIT |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.29 MYR | 0.00% |
|
-0.77% | +4.03% |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 971.5 | 964.1 | 853.7 | 922.9 | 1,041 | 1,083 | - | - |
| Enterprise Value (EV) 1 | 971.5 | 964.1 | 853.7 | 922.9 | 1,041 | 1,083 | 1,083 | 1,083 |
| P/E ratio | 12.8 x | 76.6 x | 11.6 x | 14.9 x | 16.6 x | 15.7 x | 15.4 x | 15.2 x |
| Yield | 5.87% | 5.2% | 6.72% | 6.64% | 6.37% | 6.2% | 6.28% | 6.36% |
| Capitalization / Revenue | 9.16 x | 8.33 x | 7.48 x | 8.37 x | 8.6 x | 9.03 x | 9.1 x | 9.03 x |
| EV / Revenue | 9.16 x | 8.33 x | 7.48 x | 8.37 x | 8.6 x | 9.03 x | 9.1 x | 9.03 x |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Price to Book | - | - | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 735,985 | 735,985 | 735,985 | 756,486 | 839,598 | 839,598 | - | - |
| Reference price 2 | 1.320 | 1.310 | 1.160 | 1.220 | 1.240 | 1.290 | 1.290 | 1.290 |
| Announcement Date | 25/02/20 | 22/02/21 | 28/02/22 | 24/02/23 | 22/02/24 | - | - | - |
1MYR in Million2MYR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 106.1 | 115.7 | 114.1 | 110.2 | 121 | 120 | 119 | 120 |
| EBITDA | - | - | - | - | - | - | - | - |
| EBIT | - | - | - | - | - | - | - | - |
| Operating Margin | - | - | - | - | - | - | - | - |
| Earnings before Tax (EBT) 1 | 76.15 | 13.62 | 72.78 | 60.04 | 60.55 | 72 | 74 | 74 |
| Net income 1 | 76.16 | 12.57 | 73.55 | 60.14 | 60.69 | 72 | 74 | 75 |
| Net margin | 71.78% | 10.86% | 64.48% | 54.55% | 50.15% | 60% | 62.18% | 62.5% |
| EPS 2 | 0.1035 | 0.0171 | 0.0999 | 0.0817 | 0.0745 | 0.0820 | 0.0840 | 0.0850 |
| Free Cash Flow | - | - | - | - | - | - | - | - |
| FCF margin | - | - | - | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | 0.0775 | 0.0681 | 0.0780 | 0.0810 | 0.0790 | 0.0800 | 0.0810 | 0.0820 |
| Announcement Date | 25/02/20 | 22/02/21 | 28/02/22 | 24/02/23 | 22/02/24 | - | - | - |
1MYR in Million2MYR
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - |
| ROE (net income / shareholders' equity) | 6.65% | 5.99% | 7.79% | 7.07% | 5.94% | 6.6% | 6.8% | 6.8% |
| ROA (Net income/ Total Assets) | 3.9% | 3.43% | 4.44% | 3.84% | 3.26% | 3.7% | 3.7% | 3.7% |
| Assets 1 | 1,954 | 366.5 | 1,656 | 1,567 | 1,861 | 1,946 | 2,000 | 2,027 |
| Book Value Per Share | - | - | - | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - | - | - |
| Capex | - | - | - | - | - | - | - | - |
| Capex / Sales | - | - | - | - | - | - | - | - |
| Announcement Date | 25/02/20 | 22/02/21 | 28/02/22 | 24/02/23 | 22/02/24 | - | - | - |
1MYR in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
1.29
MYR
Average target price
1.25
MYR
Spread / Average Target
-3.10%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +4.03% | 228M | |
| +3.91% | 693M | |
| -3.15% | 632M | |
| -11.19% | 592M | |
| -7.35% | 421M | |
| -1.43% | 420M | |
| -14.11% | 348M | |
| -10.28% | 298M | |
| +1.79% | 236M | |
| -19.27% | 191M |
- Stock Market
- Equities
- ALAQAR Stock
- Financials Al-'Aqar Healthcare REIT
